DK0598061T3 - Hidtil ukendte 4-oxocykliske urinstoffer, der er nyttige som anti-arrhytmiske og antifibrillerende midler - Google Patents

Hidtil ukendte 4-oxocykliske urinstoffer, der er nyttige som anti-arrhytmiske og antifibrillerende midler

Info

Publication number
DK0598061T3
DK0598061T3 DK92918467T DK92918467T DK0598061T3 DK 0598061 T3 DK0598061 T3 DK 0598061T3 DK 92918467 T DK92918467 T DK 92918467T DK 92918467 T DK92918467 T DK 92918467T DK 0598061 T3 DK0598061 T3 DK 0598061T3
Authority
DK
Denmark
Prior art keywords
nil
unsubstituted
saturated
substituted
alkyl
Prior art date
Application number
DK92918467T
Other languages
Danish (da)
English (en)
Inventor
Salvatore Jr Pelosi Stanford
Chia-Nien Yu
Arthur Calcagno Mark
Original Assignee
Procter & Gamble Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma
Application granted granted Critical
Publication of DK0598061T3 publication Critical patent/DK0598061T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/80Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
DK92918467T 1991-08-14 1992-08-10 Hidtil ukendte 4-oxocykliske urinstoffer, der er nyttige som anti-arrhytmiske og antifibrillerende midler DK0598061T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74486791A 1991-08-14 1991-08-14
PCT/US1992/006684 WO1993004061A1 (en) 1991-08-14 1992-08-10 Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents

Publications (1)

Publication Number Publication Date
DK0598061T3 true DK0598061T3 (da) 2002-11-11

Family

ID=24994275

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92918467T DK0598061T3 (da) 1991-08-14 1992-08-10 Hidtil ukendte 4-oxocykliske urinstoffer, der er nyttige som anti-arrhytmiske og antifibrillerende midler

Country Status (27)

Country Link
US (1) US5462940A (cs)
EP (2) EP1231208A3 (cs)
JP (1) JP3040473B2 (cs)
KR (2) KR100273605B1 (cs)
AT (1) ATE220675T1 (cs)
AU (1) AU668360B2 (cs)
BR (1) BR9206369A (cs)
CA (1) CA2115427C (cs)
CZ (1) CZ282368B6 (cs)
DE (1) DE69232681T2 (cs)
DK (1) DK0598061T3 (cs)
ES (1) ES2180537T3 (cs)
FI (1) FI109696B (cs)
HK (1) HK1048806A1 (cs)
HU (1) HU221317B1 (cs)
IL (1) IL102793A (cs)
MX (1) MX9204730A (cs)
MY (1) MY109205A (cs)
NO (5) NO306676B1 (cs)
NZ (1) NZ243938A (cs)
PH (1) PH31451A (cs)
PL (2) PL170984B1 (cs)
PT (1) PT100777B (cs)
RU (2) RU2221788C2 (cs)
SK (1) SK282656B6 (cs)
TW (1) TW232691B (cs)
WO (1) WO1993004061A1 (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083945A (en) * 1995-06-07 2000-07-04 The Procter & Gamble Company Cyclic ureas useful as antiarrhythmic and antifibrillatory agents
US6262068B1 (en) 1997-02-21 2001-07-17 Bristol-Myers Squibb Company Lactam derivatives as antiarrhythmic agents
WO1998037068A1 (en) 1997-02-21 1998-08-27 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
US6048877A (en) * 1997-02-21 2000-04-11 Bristol-Myers Squibb Company Tetralone derivatives as antiarrhythmic agents
US6664250B2 (en) 1998-01-20 2003-12-16 Bristol-Myers Squibb Co. Lactam derivatives as antiarrhythmic agents
EP1056726A1 (en) 1998-02-20 2000-12-06 The Procter & Gamble Company Solid phase synthesis of 1-aminohydantoins
ES2288020T3 (es) * 1998-04-29 2007-12-16 THE PROCTER & GAMBLE COMPANY Procedimiento para preparar ureas 1,3-disustituidas-4-oxociclicas.
RU2194705C2 (ru) * 1998-04-29 2002-12-20 Дзе Проктер Энд Гэмбл Компани Способ получения 1,3-дизамещенных 4-оксоциклических мочевин
SE0100733D0 (sv) * 2001-03-05 2001-03-05 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
CN100443473C (zh) * 2005-04-30 2008-12-17 中国药科大学 1-氨基-3-(氮杂环基烷基)-2,4-咪唑二酮的合成方法
ATE466873T1 (de) * 2005-10-18 2010-05-15 Seoul Nat Univ Ind Foundation Verfahren zur herstellung eines rekombinanten peptids aus spinnengift, und das peptid enthaltende analgetische zusammensetzung
US20120178762A1 (en) 2006-12-15 2012-07-12 Warner Chilcott Company, Llc Compositions of azimilide dihydrochloride
TW200840578A (en) * 2006-12-15 2008-10-16 Procter & Gamble Compositions of azimilide dihydrochloride
CN101735205B (zh) * 2009-12-17 2013-05-15 天津药物研究院 盐酸阿齐利特的晶型ⅴ及其制备方法和用途
CN101735203B (zh) * 2009-12-17 2012-05-23 天津药物研究院 盐酸阿齐利特的晶型ⅱ及其制备方法和用途
CN101735202B (zh) * 2009-12-17 2012-05-30 天津药物研究院 盐酸阿齐利特的晶型ⅰ及其制备方法和用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB939941A (en) * 1959-04-14 1963-10-16 Norwich Pharma Co Improvements in or relating to the manufacture of derivatives of 5-nitrofuran
US3182058A (en) * 1960-10-31 1965-05-04 Pfizer & Co C Nitrofuran derivatives
DE1202281B (de) * 1960-11-21 1965-10-07 Josef Klosa Dipl Chem Dr Verfahren zur Herstellung von N-(5-Nitro-2-furfuryliden)-1-aminohydantoinen
NL272957A (cs) * 1960-12-27 1900-01-01
NL272958A (cs) * 1960-12-27
FR1310188A (cs) * 1960-12-27 1963-03-06
DE1164416B (de) * 1960-12-27 1964-03-05 Norwich Pharma Co Verfahren zur Herstellung von in 3-Stellung aminoalkylierten Derivaten des 1-(5-Nitrofurfuryliden-amino)-hydantoins und ihren Salzen
DE1201845B (de) * 1962-07-14 1965-09-30 Zambon Spa Verfahren zur Herstellung von N-(5-Nitro-2-furfuryliden)-1-aminohydantoin
NL300307A (cs) * 1963-06-10
US3415821A (en) * 1965-09-07 1968-12-10 Norwich Pharma Co 1-(5-substituted)furfurylideneamino hydantoins and imidazolidinones
NL6900631A (cs) * 1968-01-26 1969-07-29
JPS5032271B2 (cs) * 1973-06-06 1975-10-18
US4001222A (en) * 1975-10-14 1977-01-04 Morton-Norwich Products, Inc. 3-(Aminoacyl)-1-{[5-(substituted phenyl)furfurylidene]amino}hydantoins and process for their preparation thereof
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4393204A (en) * 1982-05-21 1983-07-12 Norwich Eaton Pharmaceuticals, Inc. 3-[[5-(4-Chlorophenyl)furfurylidene]amino]-5-(substituted)-2-oxazolidinones
JPS5913780A (ja) * 1982-07-13 1984-01-24 Takeda Chem Ind Ltd フルオロウラシル誘導体および抗腫瘍剤
US4543359A (en) * 1982-10-01 1985-09-24 Eaton Laboratories, Inc. Treating cardiac arrhythmias with dantrolene sodium
FR2539412B1 (fr) * 1983-01-13 1986-02-21 Shoichiro Ozaki Derives du 5-fluoruracile et leurs utilisations therapeutiques en tant qu'agents carcinostatiques
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
US4720580A (en) * 1984-09-21 1988-01-19 American Home Products Corporation N-(aminoalkylene)benzenesulfonamides
US4713382A (en) * 1985-05-30 1987-12-15 Syntex (U.S.A.) Inc. N-phenyl-4-phenyl-1-piperazinecarboxamidines and related compounds as antiarrhythmic agents
US4707499A (en) * 1985-12-02 1987-11-17 G. D. Searle & Co. 3-alkyl-5-(substituted amino)methyl)dihydro-3-phenyl-2(3H)-furanones and imino analogs thereof used for treatment of arrhythmia
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
PH23283A (en) * 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof
US4804662A (en) * 1987-05-05 1989-02-14 Schering A.G. Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents
US4851526A (en) * 1987-09-04 1989-07-25 Schering A.G. 1-(4-Substituted phenyl)-1H-imidazoles compounds
US4870095A (en) * 1988-06-13 1989-09-26 Sterling Drug, Inc. 1H-pyrazole-1-alkanamides, antiarrhythmic compositions and use
EP0347733A1 (en) * 1988-06-20 1989-12-27 Eisai Co., Ltd. Optically active hydantoin derivatives
CA2020813C (en) * 1989-07-25 1995-08-01 Frederick Dana Cazer Nitrofurantoin crystals
US4966967A (en) * 1989-09-15 1990-10-30 Berlex Laboratories, Inc. 3,4,5,6-tetrahydro-2H-1,7,4-benzodioxazonines as cardiovascular agents
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
US4994459A (en) * 1989-12-11 1991-02-19 American Home Products Corporation Aryloxypropane substituted piperazine derivatives with antiarrhythmic and antifibrillatory activity
US4963561A (en) * 1990-02-28 1990-10-16 Sterling Drug Inc. Imidazopyridines, their preparation and use
EP0891976B1 (en) * 1991-08-14 2002-10-16 Procter & Gamble Pharmaceuticals Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents
AU665367B2 (en) * 1991-08-14 1996-01-04 Procter & Gamble Pharmaceuticals, Inc. Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents

Also Published As

Publication number Publication date
NO992898L (no) 1994-02-14
WO1993004061A1 (en) 1993-03-04
EP0598061B1 (en) 2002-07-17
HU221317B1 (en) 2002-09-28
SK17194A3 (en) 1995-03-08
PL170961B1 (en) 1997-02-28
NO310145B1 (no) 2001-05-28
EP1231208A3 (en) 2003-12-10
NO310148B1 (no) 2001-05-28
NO310147B1 (no) 2001-05-28
FI940657A0 (fi) 1994-02-11
FI109696B (fi) 2002-09-30
PH31451A (en) 1998-11-03
ES2180537T3 (es) 2003-02-16
NO992900D0 (no) 1999-06-14
CA2115427A1 (en) 1993-03-04
JPH06509804A (ja) 1994-11-02
NO992897D0 (no) 1999-06-14
MY109205A (en) 1996-12-31
NO940497D0 (no) 1994-02-14
HK1048806A1 (en) 2003-04-17
ATE220675T1 (de) 2002-08-15
US5462940A (en) 1995-10-31
NO940497L (no) 1994-02-14
KR100273605B1 (ko) 2000-12-15
FI940657A7 (fi) 1994-02-11
PL170984B1 (pl) 1997-02-28
AU2471792A (en) 1993-03-16
TW232691B (cs) 1994-10-21
CZ30694A3 (en) 1995-01-18
SK282656B6 (sk) 2002-11-06
MX9204730A (es) 1994-03-31
HU9400396D0 (en) 1994-05-30
NZ243938A (en) 1996-10-28
NO992899D0 (no) 1999-06-14
CA2115427C (en) 2000-05-02
NO992900L (no) 1994-02-14
NO306676B1 (no) 1999-12-06
PT100777A (pt) 1993-12-31
IL102793A (en) 1996-12-05
KR100295946B1 (ko) 2001-07-03
BR9206369A (pt) 1995-05-30
DE69232681D1 (de) 2002-08-22
RU2130935C1 (ru) 1999-05-27
CZ282368B6 (cs) 1997-07-16
DE69232681T2 (de) 2003-02-13
EP0598061A1 (en) 1994-05-25
NO992898D0 (no) 1999-06-14
HUT70152A (en) 1995-09-28
RU2221788C2 (ru) 2004-01-20
NO992899L (no) 1994-02-14
EP1231208A2 (en) 2002-08-14
NO310146B1 (no) 2001-05-28
PT100777B (pt) 1999-07-30
NO992897L (no) 1994-02-14
IL102793A0 (en) 1993-01-31
JP3040473B2 (ja) 2000-05-15
AU668360B2 (en) 1996-05-02

Similar Documents

Publication Publication Date Title
DK0598061T3 (da) Hidtil ukendte 4-oxocykliske urinstoffer, der er nyttige som anti-arrhytmiske og antifibrillerende midler
FI965020A0 (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
DK0598046T3 (da) Hidtil ukendte urinstoffer egnede som antiarrytmi- og antifibrilleringsmidler
RU94015844A (ru) 4-оксоциклические соединения мочевины, пригодные для использования в качестве антиаритмических и антифибрилляционных средств, фармацевтическая композиция, способ лечения
SE7907953L (sv) Substituerade furaner
CA2115029A1 (en) Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents
ES8703409A1 (es) Un metodo para preparar un derivado de urea sustituido con aminoalquilo
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
ES8302712A1 (es) Un nuevo procedimiento de preparacion de imidazobenzodiazepinas.
ES324379A1 (es) Un metodo para la preparacion de derivados basicos de ftalanos e isocromanos.